A shadow economy for unapproved slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Experimental Drug Gaining Popularity Online
The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged fat-burning effects. Viewers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.
Active Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Sellers promote the drug there before redirecting buyers to WhatsApp for transactions.
Understanding Retatrutide
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Professionals Express Concerns
However, physicians and pharmacists have cautions that the distribution of what is still an unapproved drug in the UK is a cause for concern and could result in users administering products of unknown origin.
Some professionals stated the popularity for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.
Regulatory Position and Implementation
Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach pharmaceutical, marketing, and customer laws, risking penalties, prosecution or prison.
Service Response and Content Elimination
Based on the social media company, the service has taken down violative material and banned related hashtags and search suggestions. The company stated it was dedicated to maintaining the service safe and allocating resources in enhancing enforcement strategies.
Digital Marketplace Activities
Research also found communities with up to nine thousand participants selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up groups with thousands of users, populated with images of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at home.
Within moments of entering one group, a vendor shared WhatsApp details, where the majority of transactions take place. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about body mass, medical conditions or previous experience.
Item Details and Pricing
Within these groups, posts display dark colored parcels with postal service labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with sterile water, or ready-to-use pens usually sold at £160 for 20 milligrams. When questioned how much time a pen should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A representative for Telegram stated it regularly monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting substances they can’t verify. Although the science behind this drug is valid, these online versions may not contain what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.
Her staff has previously seen individuals harmed by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose users to possibly serious medical dangers”.
